Recombinant Danio rerio CCR4-NOT transcription complex subunit 1 (cnot1), partial refers to a truncated version of the zebrafish CNOT1 protein produced via recombinant DNA technology. CNOT1 (UniProt ID: A4QP78) is the largest subunit of the CCR4-NOT complex, which regulates:
The "partial" designation indicates that only a specific domain or region of the full-length protein is expressed, often for structural or functional studies .
CNOT1 anchors the CCR4-NOT complex, enabling interactions with:
Deadenylases (e.g., CNOT6/7)
RNA-binding proteins (e.g., Nanos, Pumilio)
In zebrafish, CNOT1 likely facilitates mRNA turnover and translational control during development, akin to its role in mammalian systems .
| Property | Details |
|---|---|
| Organism | Danio rerio (zebrafish) |
| UniProt ID | A4QP78 |
| Sequence Coverage | Partial (e.g., residues 445–2376 inferred from homologs) |
| Function | Scaffold for deadenylase activity; mRNA decay/translation regulation |
| Expression System | Likely E. coli or HEK293 (based on mammalian homolog protocols) |
Human CNOT1 depletion disrupts deadenylation, elevates ER stress, and induces apoptosis .
Murine CNOT1 interacts with Nanos2 to regulate germ cell development .
Yeast Not1p (homolog) is essential for viability, unlike catalytic subunits .
Partial Protein Utility: Truncated CNOT1 may lack regions critical for interactions (e.g., MIF4G domain for DDX6 binding) .
Species-Specific Variations: Zebrafish CNOT1’s role in embryogenesis or regeneration remains understudied compared to mammals .
The CCR4-NOT complex is a evolutionarily conserved multiprotein complex that regulates gene expression at multiple levels, including transcription, mRNA decay, protein ubiquitylation, and translation . The complex can be functionally divided into modules: transcription (involving CNOT2, CNOT3), mRNA degradation, deadenylation (involving CNOT6/6L, CNOT7/8), and protein quality control through ubiquitination (involving CNOT4) .
CNOT1 serves as the central scaffolding subunit of the complex and is critical for both its structural integrity and function. It bridges RNA binding proteins (RBPs) and deadenylase subunits to target mRNAs for degradation . The complex structure follows a specific organization:
The N-terminus of CNOT1 associates with the Ccr4 group (Ccr4, Pop2, and Dhh1)
When CNOT1 is depleted, several thousand transcripts are affected, with most mRNAs showing increased levels due to decreased mRNA decay rates . This demonstrates CNOT1's crucial role in mRNA turnover and global gene expression regulation.
Zebrafish offers numerous advantages as a model organism for studying CNOT1 and the CCR4-NOT complex:
These characteristics make zebrafish exceptionally suitable for evaluating the function and mechanisms of CNOT1 in development, reproduction, central nervous system functioning, and metabolism .
Several methodological approaches are effective for studying recombinant CNOT1 in zebrafish models:
RNA interference (RNAi): Systematic siRNA-mediated knockdown has proven effective for studying CCR4-NOT component functions
In situ hybridization: This technique can analyze CNOT1 expression patterns during critical developmental periods, such as in prosencephalic neural folds at gestational day 8.25 in mouse models (analogous studies can be performed in zebrafish)
Targeted gene knockdown: Cardiac-specific silencing of CNOT1 orthologs has been successfully employed to study its role in heart development and function
Transgenic models: Creating transgenic zebrafish lines expressing fluorescently tagged CNOT1 can allow real-time visualization of protein localization and dynamics
Functional assessment: For cardiac studies, parameters like chamber size, contractility, and susceptibility to arrhythmia can be measured after CNOT1 manipulation
Transcriptome analysis: RNA-seq and similar techniques can identify global changes in gene expression following CNOT1 manipulation
CNOT1 plays a central role in regulating mRNA stability through the CCR4-NOT complex's deadenylation activity. Research shows that depleting CNOT1 results in a global decrease in mRNA decay rates, leading to increased steady-state levels of thousands of transcripts . This demonstrates CNOT1's critical function in controlling mRNA turnover.
The mechanism involves:
Recruitment of the CCR4-NOT complex to target mRNAs via RNA binding proteins (RBPs) or the miRNA machinery
Binding to specific sequences within the 3'UTRs of target mRNAs
CNOT1 bridging RBPs and deadenylase subunits (e.g., CNOT6/6L, CNOT7/8)
Initiation of deadenylation, which leads to mRNA degradation
For gene expression studies, researchers must consider that CNOT1 manipulation will have broad effects across the transcriptome. Interestingly, while CNOT1 depletion stabilizes mRNAs, depletion of another complex component, CNOT4, has the opposite effect and accelerates mRNA turnover . This highlights the complex regulatory interactions within the CCR4-NOT complex that researchers must account for when designing experiments.
Mutations in CNOT1 have significant implications for both development and disease modeling. Based on studies across different model organisms and human cases, several key effects can be anticipated in zebrafish models:
Neurological disorders: The association between CNOT1 variants and holoprosencephaly in humans suggests zebrafish CNOT1 mutants could serve as models for brain developmental disorders . The c.1603C>T (p.Arg535Cys) variant specifically impacts forebrain division.
Cardiac dysfunction: Silencing CNOT1/Not1 in Drosophila resulted in:
This indicates CNOT1 mutant zebrafish could effectively model cardiomyopathies and arrhythmias.
QT interval alterations: Studies suggest a link between CNOT1 and QT alterations, making CNOT1 mutant zebrafish potential models for Long-QT syndrome and related cardiac electrophysiological disorders .
Proliferation defects: CNOT1 silencing reduces proliferative capacity of cardiomyocytes , suggesting broader developmental growth abnormalities in mutant models.
Genome instability: The CCR4-NOT complex regulates and silences retrotransposons (particularly LINEs) , so CNOT1 mutations may lead to retrotransposon activation and consequent genome instability.
The phenotypic severity will likely depend on mutation type, with complete loss-of-function potentially being lethal while hypomorphic alleles may produce viable models with specific developmental defects.
The functional differences between partial and full-length recombinant CNOT1 are significant considerations for experimental design:
| Aspect | Partial CNOT1 | Full-length CNOT1 |
|---|---|---|
| Domain composition | Contains only a subset of functional domains | Contains all domains necessary for complete function |
| Interaction capabilities | Limited to proteins that bind the included domains | Can interact with all natural binding partners |
| Functional studies | Suitable for studying specific interactions or functions | Required for comprehensive functional studies |
| Stability | May have altered stability compared to full-length protein | Represents native stability characteristics |
| Dominant-negative effects | May potentially act as a dominant-negative in some contexts | Functions as the natural protein would |
When working with partial CNOT1, researchers should consider which domains are included in their construct. The N-terminus of CNOT1 associates with the Ccr4 group (Ccr4, Pop2, and Dhh1), while the C-terminus interacts with the Not group (Not2-Not5) . Therefore, a partial construct missing either region would disrupt specific protein-protein interactions and related functions.
Several significant challenges exist in studying CNOT1-mediated post-transcriptional regulation in zebrafish:
Complex multifunctionality: The CCR4-NOT complex regulates multiple steps in gene expression—transcription, mRNA decay, protein ubiquitylation, and translation —making it difficult to isolate specific CNOT1 functions.
Functional redundancy: The complex contains multiple subunits with potentially overlapping functions, complicating interpretation of knockdown experiments.
Developmental essentiality: Complete CNOT1 knockout may be lethal , necessitating conditional or partial knockdown approaches that add technical complexity.
Direct vs. indirect effects: Given CNOT1's role in global regulation of gene expression , distinguishing direct regulatory targets from downstream effects presents a significant challenge.
Tissue-specific functions: CNOT1 likely has different roles in different tissues, requiring sophisticated tissue-specific manipulation systems.
Technical adaptation: Advanced techniques like auxin-induced degron systems or transient transcriptome sequencing require adaptation for zebrafish models.
Temporal dynamics: The function of CNOT1 may vary throughout development, requiring precise temporal control of experimental manipulations.
Addressing these challenges requires combining multiple experimental approaches and carefully designed controls to disentangle the complex roles of CNOT1 in post-transcriptional regulation.
The CCR4-NOT complex shows remarkable conservation across species, though with some functional differences between zebrafish and mammals:
Developmental timing and context of CNOT1 expression
Interaction partners that may differ between species
Regulatory mechanisms controlling complex activity
Sensitivity to environmental factors affecting complex function
The zebrafish model offers unique advantages for visualizing CNOT1 activity in real-time during development due to embryo transparency , potentially providing insights difficult to obtain in mammalian models.
While specific zebrafish CNOT1 interactions aren't detailed in the search results, studies in other organisms provide valuable insights into likely conserved interactions:
Core CCR4-NOT complex interactions:
Transcriptional machinery:
RNA-related interactions:
These interactions influence experimental design in several ways:
Protein tagging strategies: Tags should be positioned to avoid disrupting key interaction interfaces
Knockdown studies: Effects may result from disruption of multiple protein-protein interactions
Domain-specific experiments: Targeted studies require constructs containing specific interaction domains
Co-immunoprecipitation design: Antibody selection should consider potential epitope masking by interacting proteins
Functional assays: Should account for the multifunctional nature of CNOT1 based on its diverse interactions
Understanding these interaction networks is crucial for designing experiments that accurately capture CNOT1 function while avoiding artifacts from disrupted protein complexes.
Zebrafish CNOT1 models offer valuable platforms for understanding human diseases due to the high conservation of gene function and physiological processes:
Neurodevelopmental disorders: The association between CNOT1 variants and holoprosencephaly makes zebrafish models valuable for studying mechanisms of forebrain development disorders. Transparent embryos allow real-time visualization of neurogenesis defects.
Cardiac diseases: CNOT1/Not1 knockdown in model organisms causes dilated cardiomyopathy and contractile dysfunction . Zebrafish cardiac function can be easily assessed through:
Heart rate measurements
Contractility assessments
Cardiac morphology visualization
Electrophysiological recordings
Arrhythmias: Evidence links CNOT1 to QT interval alterations , making zebrafish models potentially useful for studying Long-QT syndrome and related arrhythmias. The optical transparency allows direct visualization of cardiac conduction with appropriate reporters.
Developmental disorders: As CNOT1 regulates global gene expression , zebrafish models can illuminate mechanisms of developmental disorders caused by dysregulated gene expression.
Genome stability disorders: The role of CCR4-NOT in silencing retrotransposons suggests zebrafish models could provide insights into diseases related to genomic instability.
Drug screening: The high-throughput nature of zebrafish assays makes CNOT1 models valuable for screening compounds that might correct associated disease phenotypes.
The ability to generate large numbers of embryos, coupled with their external development and optical clarity, makes zebrafish particularly well-suited for high-throughput screening of genetic and pharmacological interventions targeting CNOT1-related pathologies.
Several molecular mechanisms link CNOT1 dysfunction to developmental abnormalities:
Global mRNA stability disruption: CNOT1 depletion decreases mRNA decay rates , leading to inappropriate persistence of transcripts that should be temporally regulated during development.
Transcriptional dysregulation: CNOT1 depletion increases RNA synthesis of several thousand genes while reducing expression of KRAB-Zinc-Finger-proteins (KZNFs) , disrupting the normal transcriptional program.
Retrotransposon activation: Reduced KZNF expression following CCR4-NOT inactivation leads to activation of retrotransposable elements, particularly Long interspersed Nuclear Elements (LINEs) , potentially causing genomic instability during development.
Cardiac structural abnormalities: CNOT1/Not1 knockdown results in abnormal myofibrillar structure with large gaps and disarray , suggesting direct effects on cytoskeletal organization or sarcomere assembly.
Reduced cellular proliferation: Silencing CNOT1 reduces the proliferative capacity of cardiomyocytes , potentially affecting organ growth and tissue homeostasis.
Neural patterning disruption: CNOT1 expression in prosencephalic neural folds suggests a role in forebrain patterning, with mutations potentially disrupting morphogen gradients or transcriptional responses.
These mechanisms highlight how CNOT1, through its central role in the CCR4-NOT complex, coordinates multiple levels of gene expression control essential for proper development. Disruption of this coordination can lead to developmental abnormalities affecting multiple organ systems, particularly the brain and heart.